Daniel L Cohen - Net Worth and Insider Trading
Daniel L Cohen Net Worth
The estimated net worth of Daniel L Cohen is at least $1,851 dollars as of 2024-11-13. Daniel L Cohen is the EVP, Govt. & Public Relations of Zevra Therapeutics Inc and owns about 216 shares of Zevra Therapeutics Inc (ZVRA) stock worth over $1,851. Details can be seen in Daniel L Cohen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Daniel L Cohen has not made any transactions after 2018-05-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Daniel L Cohen
Daniel L Cohen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Daniel L Cohen owns 1 companies in total, including Zevra Therapeutics Inc (ZVRA) .
Click here to see the complete history of Daniel L Cohen’s form 4 insider trades.
Insider Ownership Summary of Daniel L Cohen
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ZVRA | Zevra Therapeutics Inc | 2018-05-15 | EVP & Govt and Public Relations |
Daniel L Cohen Latest Holdings Summary
Daniel L Cohen currently owns a total of 1 stock. Daniel L Cohen owns 216 shares of Zevra Therapeutics Inc (ZVRA) as of May 15, 2018, with a value of $1,851.
Latest Holdings of Daniel L Cohen
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ZVRA | Zevra Therapeutics Inc | 2018-05-15 | 216 | 8.57 | 1,851 |
Holding Weightings of Daniel L Cohen
Daniel L Cohen Form 4 Trading Tracker
According to the SEC Form 4 filings, Daniel L Cohen has made a total of 0 transactions in Zevra Therapeutics Inc (ZVRA) over the past 5 years. The most-recent trade in Zevra Therapeutics Inc is the acquisition of 494 shares on May 15, 2018, which cost Daniel L Cohen around $50,955.
Insider Trading History of Daniel L Cohen
- 1
Daniel L Cohen Trading Performance
GuruFocus tracks the stock performance after each of Daniel L Cohen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Daniel L Cohen is 1.16%. GuruFocus also compares Daniel L Cohen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Daniel L Cohen within 3 months outperforms 3 times out of 7 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Daniel L Cohen's insider trading performs compared to the benchmark.
Performance of Daniel L Cohen
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -2.78 | | | | | |
| Relative Return to S&P 500(%) | -4.34 | | | | | |
Daniel L Cohen Ownership Network
Ownership Network List of Daniel L Cohen
Ownership Network Relation of Daniel L Cohen
Daniel L Cohen Owned Company Details
What does Zevra Therapeutics Inc do?
Who are the key executives at Zevra Therapeutics Inc?
Daniel L Cohen is the EVP & Govt and Public Relations of Zevra Therapeutics Inc. Other key executives at Zevra Therapeutics Inc include VP Fin & Corp Controller R. Laduane Clifton , director & President and CEO Neil F. Mcfarlane , and CCO & EVP & Bus. Development Joshua Schafer .
Zevra Therapeutics Inc (ZVRA) Insider Trades Summary
Over the past 18 months, Daniel L Cohen made no insider transaction in Zevra Therapeutics Inc (ZVRA). Other recent insider transactions involving Zevra Therapeutics Inc (ZVRA) include a net purchase of 1,500 shares made by Watton Corey Michael , a net purchase of 30,000 shares made by John B Bode , and a net purchase of 5,740 shares made by R. Laduane Clifton .
In summary, during the past 3 months, insiders sold 0 shares of Zevra Therapeutics Inc (ZVRA) in total and bought 500 shares, with a net purchase of 500 shares. During the past 18 months, 0 shares of Zevra Therapeutics Inc (ZVRA) were sold and 58,740 shares were bought by its insiders, resulting in a net purchase of 58,740 shares.
Zevra Therapeutics Inc (ZVRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Zevra Therapeutics Inc Insider Transactions
Daniel L Cohen Mailing Address
Above is the net worth, insider trading, and ownership report for Daniel L Cohen. You might contact Daniel L Cohen via mailing address: 2656 Crosspark Road, Suite 100, Coralville Ia 52241.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
